Zurück zur Übersicht

news

MTIP invests in Koa Health to make mental health treatment more accessible

Januar 14, 2021 + Jessica Di Palo
5 Minuten zu lesen

MTIP recently joined a EUR 30 million funding round as one of the major investors in Koa Health, a digital mental healthcare provider redefining care.

MTIP recently joined a EUR 30 million funding round as one of the major investors in Koa Health, a digital mental healthcare provider redefining care. Koa Health’s range of personalized mental health solutions are backed by science and designed to improve user wellbeing. The investment will be used to drive the company’s efforts to advance the digital mental health space and to help make mental healthcare more accessible.

Swiss healthtech investor MTIP welcomes Koa Health as its newest portfolio addition backed by MTIP Fund II. In November 2020, Koa Health successfully spun out of leading Spanish global telecommunications company, Telefónica, which will remain a shareholder and an important customer and partner as the company continues to develop its portfolio.

MTIP supports the company’s ambitions to expand internationally and scale to meet the rapidly growing demand for digital mental health products. Nearly 1 billion people worldwide are living with a mental disorder according to the World Health Organization (WHO), which has called for a substantial increase in investments to avert a global mental health crisis as the COVID-19 pandemic continues. There has never been a greater need for digital solutions to support individuals’ mental health than now.

The company’s debut product is Koa Foundations, a mental wellbeing app helping organizations better support their employees. Following its recent launch, Koa Foundations is already in use by dozens of companies with a combined employee population of over 250,000. Koa Foundations offers its users a library of evidence-based activities to improve their wellbeing. This includes tackling stress, sleeping better, aiding relaxation, positive thinking as well as boosting self-confidence. Supported by MTIP’s investment, the company will launch a wide range of mental health solutions, from digital wellbeing to digital therapeutics, to improve users’ mental wellbeing as well as helping them access mental health services anytime, anywhere.

As part of its continued development, Koa Health will increase investment in clinical trials and scale R&D to further personalize its products. The company is closely collaborating with different organizations, such as the Massachusetts General Hospital (the #1 US-ranked hospital for psychiatry and psychology), and the Birmingham and Solihull Mental Health NHS Foundation Trust in the UK.

Oliver Harrison, CEO of Koa Health, comments proudly on the young company’s achievements and on the potential of the new partnership with MTIP: “It is increasingly clear that digital technology has the potential to help close the growing demand gap in mental healthcare. However, the field has been limited by the inherent challenges of providing an integrated, evidence-based, ethical, and personal solution that fits the needs of users and customers. Because of Telefónica’s support, we have been able to deliver this solution. With MTIP’s investment and active support, Koa Health will expand internationally, invest more in clinical trials, and continue to develop personalized products. Our goal is to provide easy access to a range of digital mental health solutions that help people flourish in a challenging and changing world.”

David Germonpré, Partner at MTIP, who joins the Board of Directors, said: “Koa Health offers simple, trusted, and personalized solutions that are integrated from prevention to symptom management to clinical care. The digital-first approach means they are scalable and affordable, with no compromise on quality. We were pleasantly surprised by the innovative force of the company’s technology and the deep knowledge of its team to scale rapidly on a global level.” Dr. Christoph Kausch, Managing Partner at MTIP, continued: “The demand for mental health services is dramatically increasing on a global level. We consider Koa Health to be best placed to lead the global expansion of digital mental health solutions. As a spin-out of Telefónica’s moonshot project their readiness impressed us deeply, and we are pleased to support them in their mission to provide better access to treatment for mental health issues”.

 

For more Information please contact:

Jessica Di Palo @MTIP

E-Mail: communications@mtip.ch

 

ABOUT KOA HEALTH

Koa Health is the only digital mental healthcare provider that offers integrated mental health solutions, from improving wellbeing to supporting treatment for a range of common mental disorders. Koa Health’s solutions are personalized services with proven user outcomes. Headquartered in the Netherlands, Koa Health has operations in Barcelona, the US and the UK. Koa Health partners with leading clinicians and academics including Massachusetts General Hospital, University College of London, the London School of Economics, Birmingham and the Solihull Mental Health NHS Foundation Trust.

For more information, please visit www.koahealth.com

ABOUT MTIP

MTIP is a pan-European healthtech growth capital investor, based in Basel Switzerland. We invest in digital health and digitally connected medical device companies, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.

For more information, please visit www.mtip.ch

 

Share the Article

blog

Dealroom Report: Tooling the Physicians of the Future

European startups addressing clinical capacity bottlenecks

press

MTIP Office Featured in Swiss Office Blog

MTIP Office Featured in Swiss Office Blog

blog

Diversity, Equity, and Inclusion: The 3 Key Drivers for Success – An Interview with Caroline Noublanche

Dieser Text erscheint auf allen Übersichtsseiten (z.B. Story-Karussell)

blog

Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

MTIP Co-Founder and Managing Partner Dr. Christoph Kausch gives insight into growth capital decisions.

news

Rahel Hafner passed the Certificate in ESG Investing by CFA Institute

Rahel Hafner Receives Certificate in ESG Investing

news

MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held unter the motto: „Surfing the Healthtech Waves of Change“.

blog

What Makes a Great Founder/Investor Relationship?

Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva

news

Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022

news

MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment

news

MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium

blog

Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development

blog

The psychology of decision making

What makes a good investor?

news

MTIP schliesst zweiten Healthtech Growth Fonds mit $250 Millionen

MTIP schliesst zweiten Healthtech Fund

blog

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!

news

MTIP invests in Mediktor

Dieser Text erscheint auf allen Übersichtsseiten (z.B. Story-Karussell)

news

MTIP invests in Mediktor

MTIP investiert in medizinischen Assistenten

blog

SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right

news

MTIP participates in Oviva’s new $80m Series C funding

MTIP invests in Oviva

news

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia

blog

Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey

blog

Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog

How to pitch to a healthtech Investor

Blog Pitching

}